RANTES as a novel biomarker for atherogenic dyslipidemia and metabolic disturbances in patients with Type 2 Diabetes
Last updated: 01 Jan 2025
10.21608/ejchem.2021.55814.3177
RANTES, VEGF, Type 2 Diabetes, Atherogenic dyslipidemia, BMI
Moushira
Zaki
Biological Anthropology Department, National Research Centre, Giza, Egypt.
moushiraz@yahoo.com
Cairo
Sanaa
Kamal
Biological Anthropology Department, National Research Centre, Giza, Egypt.
sanaa@yahoo.com
Hala
El-Bassyouni
T
Clinical Genetics Department, National Research Centre, Cairo, Egypt.
lbassyouni@yahoo.com
Mona Abd Elmotaleb A.
Hussein
Internal Medicine National Institute of Diabetes and Endocrinology, Cairo, Egypt
abd@yahoo.com
Hend M.
Tawfeek
Internal Medicine Faculty of Medicine, Al-Azhar University- Girls
tawfeek@yahoo.com
Mina Wassef
Girgiss
Medical Department, Medical Research Division, National Research Centre, Giza, Egypt
wassef@yahoo.com
Nadia
Ahmed
Medical Biochemistry Department, Medical Research Division, National Research Centre, Giza, Egypt
mohamed@yahoo.com
0000-0001-9151-5920
Hisham A. Aziz
Orban
Medical Biochemistry Department, Medical Research Division, National Research Centre, Giza, Egypt
orban@yahoo.com
Amr
Ibrahim
Medical Biochemistry Department, Medical Research Division, National Research Centre, Giza, Egypt
ibrahim@yahoo.com
Eman
Youness
Medical Biochemistry Department, Medical Research Division, National Research Centre, Giza, Egypt
youness@yahoo.cim
64
4
22914
2021-04-01
2020-12-30
2021-04-01
1,859
1,865
0449-2285
2357-0245
https://ejchem.journals.ekb.eg/article_140621.html
https://ejchem.journals.ekb.eg/service?article_code=140621
19
Original Article
297
Journal
Egyptian Journal of Chemistry
https://ejchem.journals.ekb.eg/
RANTES as a novel biomarker for atherogenic dyslipidemia and metabolic disturbances in patients with Type 2 Diabetes
Details
Type
Article
Created At
22 Jan 2023